Hep C – We have studied Hep C and other forms of hepatitis for more than 15 years. Our research includes HCV, HAV, HBC, and EBV as well as numerous treatments and combinations of treatments for these conditions and their co-morbidities, including HIV. Much of this research has been focused on HCV, including various multi-drug regimens including interferon-based treatment cocktails of medications. We also conducted more than 10 studies on the use of CSFs for the treatment of neutropenia in HCV patients.
HIV / AIDS – Our firm’s scientists have done extensive research in the HIV / AIDS market for two decades, including several studies on AIDS-related infections.